Pieter De Pauw
Overview
Explore the profile of Pieter De Pauw including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
649
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Desouter A, Keymeulen B, Demeester S, Van de Velde U, De Pauw P, Van Dalem A, et al.
Diabetes Res Clin Pract
. 2023 Oct;
205:110974.
PMID: 37884063
Aims: In recent-onset type 1 diabetes, clamp-derived C-peptide predicts good response to anti-CD3. Elevated proinsulin and proinsulin/C-peptide ratio (PI/CP) suggest increased metabolic/inflammatory beta cell burden. We reanalyzed trial data to...
2.
Gevenois P, De Pauw P, Schoonooghe S, Delporte C, Sebti T, Amighi K, et al.
J Immunol
. 2021 Oct;
207(10):2608-2620.
PMID: 34645688
IL-13 is a pleiotropic cytokine mainly secreted by Th2 cells. It reacts with many different types of cells involved in allergy, inflammation, and fibrosis, e.g., mastocytes, B cells, and fibroblasts....
3.
Van Dalem A, Demeester S, Balti E, Keymeulen B, Gillard P, Lapauw B, et al.
PLoS One
. 2017 Jun;
12(6):e0179108.
PMID: 28570714
[This corrects the article DOI: 10.1371/journal.pone.0166702.].
4.
Van Dalem A, Demeester S, Balti E, Keymeulen B, Gillard P, Lapauw B, et al.
PLoS One
. 2016 Dec;
11(12):e0166702.
PMID: 27907006
Background: The hyperglycemic clamp test, the gold standard of beta cell function, predicts impending type 1 diabetes in islet autoantibody-positive individuals, but the latter may benefit from less invasive function...
5.
Romao E, Morales-Yanez F, Hu Y, Crauwels M, De Pauw P, Hassanzadeh G, et al.
Curr Pharm Des
. 2016 Sep;
22(43):6500-6518.
PMID: 27669966
Background: The discovery of functional heavy chain-only antibodies devoid of light chains in sera of camelids and sharks in the early nineties provided access to the generation of minimal-sized, single-domain,...
6.
Ling Z, De Pauw P, Jacobs-Tulleneers-Thevissen D, Mao R, Gillard P, Hampe C, et al.
J Clin Endocrinol Metab
. 2015 Mar;
100(6):2314-21.
PMID: 25816051
Context And Objective: Intraportal islet transplantation can restore insulin production in type 1 diabetes patients, but its effect is subject to several interfering processes. To assess the influence of β-cell...
7.
Patris S, De Pauw P, Vandeput M, Huet J, Van Antwerpen P, Muyldermans S, et al.
Talanta
. 2014 Aug;
130:164-70.
PMID: 25159394
A chip format sandwich-type immunoassay based on Nanobodies(®) (Nbs) with the Human Epidermal Growth Factor Receptor (HER2) extracellular domain as antigen model has been developed. The HER2 is considered as...
8.
Hassanzadeh-Ghassabeh G, Devoogdt N, De Pauw P, Vincke C, Muyldermans S
Nanomedicine (Lond)
. 2013 Jun;
8(6):1013-26.
PMID: 23730699
Nanobodies are recombinant, antigen-specific, single-domain, variable fragments of camelid heavy chain-only antibodies. The innate supremacy of nanobodies as a renewable source of affinity reagents, together with their high production yield...
9.
Gillard P, Vandemeulebroucke E, Keymeulen B, Pirenne J, Maes B, De Pauw P, et al.
Transplantation
. 2009 Feb;
87(3):402-7.
PMID: 19202446
Background: To compare functional beta-cell mass and insulin sensitivity in insulin-independent pancreas-kidney recipients with that in age- and body mass index-matched nondiabetic kidney recipients and normal controls. Methods: All transplant...
10.
Keymeulen B, Vandemeulebroucke E, Ziegler A, Mathieu C, Kaufman L, Hale G, et al.
N Engl J Med
. 2005 Jun;
352(25):2598-608.
PMID: 15972866
Background: Type 1 diabetes mellitus is a T-cell-mediated autoimmune disease that leads to a major loss of insulin-secreting beta cells. The further decline of beta-cell function after clinical onset might...